Literature DB >> 8815795

The trefoil peptide family.

B E Sands1, D K Podolsky.   

Abstract

The unique three-loop structure of the trefoil motif, formed by intrachain disulfide bonds in a 1-5, 2-4, 3-6 configuration between six conserved cysteine residues, is the defining feature of a recently recognized family of peptides. Expression of trefoil peptides is closely related to that of mucin glycoproteins in diverse biological sources. Three distinct members of the family (pS2, intestinal trefoil factor, and spasmolytic polypeptide) are produced in the mammalian gastrointestinal tract by mucus-secreting cells and targeted primarily for luminal secretion. The compact structure of the trefoil motif may be responsible for marked resistance of trefoil peptides to proteolytic digestion, enabling them to function in the harsh environment of the gastrointestinal lumen. Trefoil peptides are ectopically expressed adjacent to areas of inflammation within the gastrointestinal tract and may play an important role in both maintaining the barrier function of mucosal surfaces and facilitating healing after injury.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815795     DOI: 10.1146/annurev.ph.58.030196.001345

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  56 in total

Review 1.  Peptide gene expression in gastrointestinal mucosal ulceration: ordered sequence or redundancy?

Authors:  W M Wong; R J Playford; N A Wright
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

Review 2.  Trefoil peptides.

Authors:  W M Wong; R Poulsom; N A Wright
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

3.  The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation.

Authors:  D Taupin; D C Wu; W K Jeon; K Devaney; T C Wang; D K Podolsky
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 4.  Mucins and toll-like receptors: kith and kin in infection and cancer.

Authors:  Shikha Tarang; Sushil Kumar; Surinder K Batra
Journal:  Cancer Lett       Date:  2012-02-03       Impact factor: 8.679

Review 5.  Can we protect the gut in critical illness? The role of growth factors and other novel approaches.

Authors:  Jessica A Dominguez; Craig M Coopersmith
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

6.  In Vitro Investigation of the Immunomodulatory Potential of Probiotic Lactobacillus casei.

Authors:  Thirugnanam Karthikeyan; Mariappan Pravin; Velusamy Shanmuganathan Muthusamy; Rajaganapathy Bharathi Raja; Baddireddi Subhadra Lakshmi
Journal:  Probiotics Antimicrob Proteins       Date:  2013-03       Impact factor: 4.609

7.  Intestinal trefoil factor confers colonic epithelial resistance to apoptosis.

Authors:  D R Taupin; K Kinoshita; D K Podolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

Review 8.  Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?

Authors:  P R Gibson; J G Muir
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

9.  Induction of trefoil factor (TFF)1, TFF2 and TFF3 by hypoxia is mediated by hypoxia inducible factor-1: implications for gastric mucosal healing.

Authors:  C Hernández; E Santamatilde; K J McCreath; A M Cervera; I Díez; D Ortiz-Masiá; N Martínez; S Calatayud; J V Esplugues; M D Barrachina
Journal:  Br J Pharmacol       Date:  2008-12-09       Impact factor: 8.739

10.  Impaired mucosal regeneration in neonatal necrotising enterocolitis.

Authors:  Daniela Vieten; Anthony Corfield; Daniel Carroll; Pramila Ramani; Richard Spicer
Journal:  Pediatr Surg Int       Date:  2004-12-02       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.